Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


QUOTED. Jan. 10, 2019. Scott Gottlieb.

Executive Summary

FDA will soon begin real-world testing of its "pre-cert" program for health software to find out if the program can be carried out within the agency's current regulatory authorities. FDA commissioner Scott Gottlieb believes it can be.

"We believe the most efficient way to test this type of program is to do so within the FDA’s current regulatory authorities. We know many stakeholders have had questions about how this would work." - Scott Gottlieb, commissioner, US FDA

Click here for a free trial of Medtech Insight


Related Content

2019 Will Be Testing Period For US FDA's Novel Pre-Cert Paradigm For Digital Health





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts